PBGH Announcements


April 14, 2021

Consumers First’s 2021 Administrative Agenda Calls on President Biden to Address Health Care’s Inefficiencies, Inequities, and Market Failures

Consumers First’s 2021 Administrative Agenda Calls on President Biden to Address Health Care’s Inefficiencies, Inequities, and Market Failures.

placeholder image
April 6, 2021

PBGH’s Emma Hoo Appointed by GAO to New Advisory Committee

Comptroller General of the United States and head of the U.S. Government Accountability Office (GAO), today announced the appointment of six members, including PBGH’s Emma Hoo, to the newly created State All Payer Claims Databases Advisory Committee (SAPCDAC).

March 25, 2021

PBGH Launches Primary Care Collaborative to Improve Chronic Disease Care in a Virtual Setting

Participating organizations serve over 750,000 patients across California’s Central Valley and Inland Empire, where patients with diabetes and asthma have poorer clinical outcomes compared to the rest of the state.

March 2, 2021

PBGH CEO Testifies to Energy & Commerce Health Subcommittee on Telehealth

PBGH CEO, Elizabeth Mitchell, testifies on telehealth and its rapid adoption during the pandemic to the House Committee on Energy & Commerce, Subcommittee on Health.

February 24, 2021

PBGH Supports Xavier Becerra’s Nomination for HHS Secretary

PBGH offers its strong support for the nomination of Xavier Becerra for Secretary of the Department of Health and Human Services.

February 9, 2021

PBGH Offers COVID Bill Recommendations

PBGH joined 25 other organizations representing many of the nation’s leading private and public sector employers, to offer recommendations for forthcoming legislation to mitigate the COVID-pandemic and restore our economy.

January 27, 2021

PACIFIC BUSINESS GROUP ON HEALTH CHANGES NAME

Now Purchaser Business Group on Health, PBGH has changed its name to reflect its national presence and purchaser-only membership.

January 6, 2021

Trump Administration Announces Executive Orders to Reduce Drug Prices

On Friday, July 24, the President signed four executive orders aimed at reducing prescription drug prices. While executive orders do not need congressional approval, each of these orders requires further rulemaking and are thus not immediately enforceable. In addition, all four orders will be fought in the courts by affected stakeholders and the orders could be withdrawn by a future administration. Nevertheless, if ever finalized, the orders could have a significant impact on drug costs in the future.

January 6, 2021

HHS Secretary Azar calls on CQC to host roundtable on COVID’s impact primary care

PBGH’s California Quality Collaborative hosted leading voices in health reform to address enhanced access to health care beyond the pandemic. 
Read the statement.

December 4, 2020

EmployersRx calls on Congress and industry to ensure fair and reasonable pricing for COVID-19 vaccines and therapeutic drugs.

As the COVID-19 crisis will only end when people have access to effective vaccines and therapeutic drugs, EmployersRx urges legislators, manufacturers and providers to ensure fair and reasonable pricing of these shortly anticipated treatments.